Defibrotide for the Treatment of Severe COVID-19

Pharmacokinetics, Pharmacodynamics, and Safety of Single-dose Sotrovimab in High-risk Pediatric Participants With Mild to Moderate COVID-19

NCT05124210 ·Status: TERMINATED ·Phase: PHASE2

Atovaquone for Treatment of COVID-19

NCT04456153 ·Status: COMPLETED ·Phase: PHASE2

Prevention of COVID-19 Infection to Severe Pneumonia or ARDS

NCT04569227 ·Status: UNKNOWN ·Phase: PHASE2

Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Hospitalized Adults With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure

NCT04705597 ·Status: TERMINATED ·Phase: PHASE2

Efficacy of Tocilizumab on Patients With COVID-19

NCT04356937 ·Status: COMPLETED ·Phase: PHASE3

SLV213 Treatment in Ambulatory COVID-19 Patients

NCT04843787 ·Status: UNKNOWN ·Phase: PHASE2

Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19)

NCT04487886 ·Status: COMPLETED ·Phase: PHASE2

Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization

NCT04439006 ·Status: COMPLETED ·Phase: PHASE1

Intranasal INNA-051 for Prevention of COVID-19 in Adults

NCT05118763 ·Status: WITHDRAWN ·Phase: PHASE2

A Prospective, Phase II Study to Evaluate Safety of 101-PGC-005 ('005) for Moderate to Severe COVID-19 Disease Along With Standard of Care

NCT05195749 ·Status: TERMINATED ·Phase: PHASE2

Duvelisib to Combat COVID-19

NCT04372602 ·Status: COMPLETED ·Phase: PHASE2

SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation

NCT04631705 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.

NCT04535167 ·Status: COMPLETED ·Phase: PHASE1

A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19

NCT05545319 ·Status: WITHDRAWN ·Phase: PHASE2

DEFINE - Evaluating Therapies for COVID-19

NCT04473053 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of Obeldesivir in Nonhospitalized Participants With COVID-19

NCT05715528 ·Status: COMPLETED ·Phase: PHASE3

LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)

NCT05077332 ·Status: COMPLETED ·Phase: PHASE2

Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults

NCT04625972 ·Status: COMPLETED ·Phase: PHASE3

Exploratory Study of Aerosol Inhalation of FB2001 for Post-exposure Prophylaxis of COVID-19 Close Contacts

NCT05415241 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Study of Obeldesivir in Participants With COVID-19 Who Have a High Risk of Developing Serious or Severe Illness

NCT05603143 ·Status: TERMINATED ·Phase: PHASE3

A Decentralized, Randomized Phase 2 Efficacy and Safety Study of Nirmatrelvir/Ritonavir in Adults with Long COVID.

NCT05668091 ·Status: COMPLETED ·Phase: PHASE2

Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older

NCT04798027 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants

NCT04382586 ·Status: COMPLETED ·Phase: PHASE2

Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19

NCT04528667 ·Status: COMPLETED ·Phase: PHASE2

Safety Study of SLV213 for the Treatment of COVID-19.

NCT06146374 ·Status: TERMINATED ·Phase: PHASE1